Digital AI in cancer diagnostics and devices: Where we are, and wher... While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society.
Oncology Single-cell multi-omics and oncological potential Just like people, no two cancer cells are alike.
Cancer Targeting the ecosystem to make cancer extinct The ICR and The Royal Marsden have embarked on an ambitious research collaboration to disrupt the cancer cell ecosystem.
News FDA clears first at-home device for depression Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.